Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
LTRN
$2.65
+0.76%
LTRN · Lantern Pharma Inc.
$2.65
+0.02 (+0.76%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“there is substantial doubt about the Company's ability to continue as a going concern in the absence of obtaining substantial additional funding.”View the 10-Q filed Aug 14, 2026
Market Cap
$33.88M
Shares
12.78M
All earnings calls
Earnings call · FY2026 Q2
Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET
Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Diluted EPS
-$0.57
Net income
-$7.07M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 14, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 14, 2026 · complete as-filed document